数据加载中.....
|
jsp.display-item.identifier=請使用永久網址來引用或連結此文件:
https://ir.cnu.edu.tw/handle/310902800/27645
|
| 標題: | alpha-Lipoic acid prevents mild portal endotoxaemia-induced hepatic inflammation and beta cell dysfunction |
| 作者: | Tian, Yu-Feng
Hsieh, Chang-Hsun
Hsieh, Yen-Ju
Chen, Yu-Ting
Peng, Yi-Jen
Hsieh, Po-Shiuan |
| 貢獻者: | 保健營養系 |
| 關鍵字: | A-Lipoic Acid
Beta Cell Dysfunction
Chronic Hepatic Inflammation
Oxidative Stress
Portal Endotoxaemia |
| 日期: | 2012-06 |
| 上傳時間: | 2014-03-21 16:16:19 (UTC+8) |
| 出版者: | Wiley-Blackwell |
| 摘要: | Eur J Clin Invest 2012; 42 (6): 637648 Abstract Background This study was undertaken to evaluate the preventive effect of a-lipoic acid (LA) on chronic mild portal endotoxaemia-mediated subacute hepatic inflammation and pancreatic beta cell dysfunction in rats. Materials and methods Male SpragueDawley rats were randomly assigned into four groups: those with intraportal vehicle (saline) or low-dose lipopolysaccharide (LPS) (0.42 ng/kg/min) infusion, combined with oral administration of vehicle or LA, a potent antioxidant (60 mg/kg/day) for 4 weeks. The hyperglycaemic clamp and euglycaemic clamp techniques were used to access the glucose-stimulated insulin secretion and systemic insulin sensitivity in vivo. Results Body weight, fasting plasma glucose and insulin were not different among groups. In rats with chronic intraportal LPS infusion, plasma C-reactive protein, amylase, superoxide levels, the contents of thiobarbituric acid-reactive substance, tumour necrosis factor a and interleukin 6 in liver and pancreas and also the gene expression of Toll-like receptor 4 in liver were significantly increased as compared with those with LA cotreatment. The histopathological examination showed that inflammatory changes were clearly visible in liver and pancreatic islets of LPS-infused rats and rarely observed in those cotreated with LA. In addition, low-dose intraportal LPS infusion also significantly impaired glucose-stimulated insulin secretion but not affect the systemic insulin sensitivity and metabolic clearance rate of insulin. LA administration markedly reversed LPS-induced beta cell dysfunction. Conclusions a-Lipoic acid cotreatment could significantly prevent mild portal endotoxaemia-induced chronic hepatic inflammation and impaired pancreatic insulin secretion in absence of changing systemic insulin resistance. |
| 關聯: | European Journal of Clinical Investigation, 42(6), 637-648 |
| 显示于类别: | [保健營養系(所) ] 期刊論文
|
文件中的档案:
| 档案 |
描述 |
大小 | 格式 | 浏览次数 |
|---|
| index.html | | 0Kb | HTML | 2893 | 检视/开启 |
|
在CNU IR中所有的数据项都受到原著作权保护.
|
